Adamas Pharmaceuticals, Inc. engages in the development and commercialization of controlled release combination therapeutics to treat healthcare problems, primarily in the areas of infectious diseases and central nervous system disorders. It also develops novel extended release and combination products for symptomatic treatment of dementia. The company was incorporated in 2000 and is headquartered in Emeryville, California with operations in India, the United States, and Singapore.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Adamas Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Adamas Pharmaceuticals Inc market cap is $376.37M.
What is the 52-week high for Adamas Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Adamas Pharmaceuticals Inc 52 week high is $9.15 as of October 03, 2025.
What is the 52-week low for Adamas Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Adamas Pharmaceuticals Inc 52 week low is $4.02 as of October 03, 2025.
What is Adamas Pharmaceuticals Inc stock price today?
Adamas Pharmaceuticals Inc stock price today is $8.22.
What was Adamas Pharmaceuticals Inc stock price yesterday?
Adamas Pharmaceuticals Inc stock price yesterday was $8.16.
What is the PE ratio of Adamas Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Adamas Pharmaceuticals Inc’s P/E ratio is -4.85.
What is the Price-to-Book ratio of Adamas Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Adamas Pharmaceuticals Inc P/B ratio is -17.3828.
What is the 50-day moving average of Adamas Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Adamas Pharmaceuticals Inc 50-day moving average is $7.00.